Document is current
Any future updates will be listed below
-
Authors
Jain, Mahim
Shah, Mehul
Thakker, Kamlesh M.
Rava, Andrew
Pelts Block, Agnes
Ndiba-Markey, Colette
Pinto, Lionel
- License Information
-
More Information
Article History
Received: 30 May 2024
Accepted: 27 December 2024
First Online: 24 January 2025
Declarations
:
: Optum data only contains de-identified health information as described by the HIPAA Privacy Rule. No direct identifiers of individuals, employers, households, or providers are included. Since Optum data is de-identified and its use does not require IRB approval, it typically does not require patient consent.
: Not applicable.
: MJ has received consultancy fees from Travere Therapeutics, Inc. MS is an employee and stock/options holder (vested and unvested) of Travere Therapeutics, Inc. KMT is an employee of Notting Hill Consulting LLC which has received consulting fees from Travere Therapeutics, Inc. AR is an employee of Genesis Research Group, which receives consulting fees from Travere Therapeutics, Inc. for this study and other related studies. APB is an employee and stockholder of Travere Therapeutics Inc. CNM was an employee of Genesis Research Group at the time of the study, which receives consulting fees from Travere Therapeutics, Inc. for this study and other related studies. LP is a former employee and stock/options holder (vested and unvested) of Travere Therapeutics, Inc.
